TrialComplementary therapies in medicine2022

AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India.

Harbans Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.